NCT06921330

Brief Summary

This study aims to examine the effect of white cover and massage application on bilirubin levels and phototherapy duration in newborns with ABO incompatibility receiving phototherapy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 28, 2025

Completed
13 days until next milestone

First Posted

Study publicly available on registry

April 10, 2025

Completed
7 months until next milestone

Study Start

First participant enrolled

November 1, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2026

Completed
3 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 4, 2026

Completed
Last Updated

April 9, 2026

Status Verified

April 1, 2026

Enrollment Period

5 months

First QC Date

March 28, 2025

Last Update Submit

April 4, 2026

Conditions

Keywords

ABO incompatibilitynewbornphototherapyWhite covermassageHyperbilirubinemia

Outcome Measures

Primary Outcomes (2)

  • Change in bilirubin level

    Capillary bilirubin levels will be measured immediately before the initiation of phototherapy and immediately after the termination of phototherapy. The change in capillary bilirubin levels will be calculated and reported.The unit of measure for bilirubin levels will be milligrams per deciliter (mg/dL).

    From immediately before initiation of phototherapy to immediately after termination of phototherapy

  • Duration of phototherapy

    The total duration of phototherapy required until bilirubin levels decreased below the treatment threshold will be recorded.The unit of measure for the duration of phototherapy is hours.

    From initiation to termination of phototherapy

Study Arms (2)

intervention group

EXPERIMENTAL

1. During phototherapy, the phototherapy devices of term newborns with abo incompatibility will be covered with white cover. 2. During phototherapy, infant massage including facial massage, chest massage, arm massage, abdominal massage and leg massage will be applied to term newborns twice a day for 15 minutes each session with an interval of 6 hours.

Other: white cover-newborn massage

control group

NO INTERVENTION

The hospital's clinical routine will be applied to the newborns in the control group.

Interventions

A white cover will be covered over the incubator during phototherapy. Baby massage will be applied during phototherapy.

Also known as: white cover and massage
intervention group

Eligibility Criteria

Age12 Hours - 1 Month
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Abo-Incompatibility term babies with a gestational age between 37-42 weeks,
  • Does not have a respiratory, cardiovascular, gastrointestinal or neurological disorder or syndrome that would prevent or complicate oral feeding,
  • Birth weight of 2500 g and above,
  • With phototherapy indication,
  • Do not have any health problems other than neonatal jaundice detected in the prenatal period,
  • Those with a stable health condition,
  • Orally fed,
  • No clinical signs of dehydration,
  • Do not have any skin problems that would prevent baby massage,
  • Newborns with written and verbal informed consent from their families will be included in the study.

You may not qualify if:

  • Premature,
  • Those with congenital malformations,
  • Those with hyperbilirubinemia requiring exchange transfusion,
  • Those with Rh hemolytic disease,
  • Having a positive culture test (sepsis),
  • Those with glucose-6-phosphate dehydrogenase (G6PD) deficiency,
  • Birth weight below 2500 grams,
  • Those who were referred to another center during the research,
  • Discharged early,
  • Unexpected complications developed during the research,
  • Bronze child syndrome occurs during phototherapy,
  • Newborns who develop a pathology that will prevent or complicate oral feeding will not be included in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Karabük Eğitim Ve Araştırma Hastanesi

Karabük, Karabük Province, 78020, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Jaundice, NeonatalHyperbilirubinemia, NeonatalHyperbilirubinemia

Interventions

Massage

Condition Hierarchy (Ancestors)

Infant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Therapy, Soft TissueMusculoskeletal ManipulationsComplementary TherapiesTherapeuticsPhysical Therapy ModalitiesRehabilitation

Study Officials

  • Zeynep ze ÇİFTCİ DEMİRTAŞ, 1

    midwife

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Midwife

Study Record Dates

First Submitted

March 28, 2025

First Posted

April 10, 2025

Study Start

November 1, 2025

Primary Completion

April 1, 2026

Study Completion

April 4, 2026

Last Updated

April 9, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations